Common Contracts
20 similar Underwriting Agreement contracts by Blue Sphere Corp., Kidpik Corp., Acasti Pharma Inc., others
VISION MARINE TECHNOLOGIES INC. UNDERWRITING AGREEMENTUnderwriting Agreement • December 4th, 2023 • Vision Marine Technologies Inc. • Ship & boat building & repairing • New York
The undersigned, Vision Marine Technologies Inc., a corporation organized under the laws of Quebec, Canada (the "Company"), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters”), for whom Joseph Gunnar & Co., LLC is acting as representative (in such capacity, the “Representative”), an aggregate of (i) [ ] common shares (the “Firm Shares”), no par value, of the Company (the “Common Shares”), (ii) [ ] pre-funded warrants (each a “Pre-Funded Warrant” and collectively, the “Pre-Funded Warrants”), with each Pre-Funded Warrant exercisable to purchase one Common Share (the “Pre-Funded Warrant Shares”) at a remaining exercise price of $0.001 per share and (iii) warrants to purchase [ ] Common Shares (each a “Warrant” and collectively, the “Warrants”). The Firm Shares, Pre-Funded Warrants and Warrants are referred to herein as the “Firm S
MILLENNIUM GROUP INTERNATIONAL HOLDINGS LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • March 3rd, 2023 • Millennium Group International Holdings LTD • Commercial printing • New York
The undersigned, Millennium Group International Holdings Limited, a Cayman Islands exempted company (the “Company”), hereby confirms its agreement (this “Agreement”) with Revere Securities LLC (the “Representative”) R.F. Lafferty & Co. Inc. (“R.F. Lafferty”) and the several underwriters named on Schedule A hereto (each, an “Underwriter” and collectively, the “Underwriters”) for which the Representative is acting as representative to issue and sell to the Underwriters an aggregate of [●] Ordinary Shares, par value $0.002, of the Company (“Shares”). The offering and sale of securities contemplated by this Agreement is referred to herein as the “Offering.”
BLUE WATER VACCINES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 8th, 2022 • Blue Water Vaccines Inc. • Pharmaceutical preparations • New York
The undersigned, Blue Water Vaccines, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Boustead Securities, LLC is acting as representative (in such capacity, the “Representative”), an aggregate of 2,222,222 shares (the “Shares”) of common stock of the Company, par value $0.0001 per share (the “Common Stock”) The offering and sale of the Shares contemplated by this Agreement is referred to herein as the “Offering.”
UNDERWRITING AGREEMENTUnderwriting Agreement • November 5th, 2021 • Kidpik Corp. • Retail-catalog & mail-order houses • New York
The undersigned, Kidpik Corp., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which EF Hutton, division of Benchmark Investments LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • October 29th, 2021 • Kidpik Corp. • Retail-catalog & mail-order houses • New York
The undersigned, Kidpik Corp., a company incorporated under the laws of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which EF Hutton, division of Benchmark Investments LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
HALL OF FAME RESORT & ENTERTAINMENT COMPANY UNDERWRITING AGREEMENTUnderwriting Agreement • February 5th, 2021 • Hall of Fame Resort & Entertainment Co • Services-miscellaneous amusement & recreation • New York
The undersigned, Hall of Fame Resort & Entertainment Company, a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of ________ shares (the “Firm Shares”) of common stock, par value $0.0001 per share (the “Common Stock”) and, at the election of the Representative, up to an additional ________ shares of Common Stock (the “Option Shares” and collectively with the Firm Shares, the “Shares” or the “Securities”). The offering and sale of the Securities contemplated by this Agreement is referred to herein as the “Offering.”
VIVOPOWER INTERNATIONAL PLC UNDERWRITING AGREEMENTUnderwriting Agreement • October 9th, 2020 • VivoPower International PLC • Electric & other services combined • New York
The undersigned, VivoPower International PLC., a public limited company incorporated under the laws of England and Wales (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of ____________ Ordinary Shares, nominal value $0.012 per share (the “Firm Shares”) of the Company (“Ordinary Shares”), and, at the election of the Representative, up to an additional _____________ Option Shares (as defined herein and collectively with the Firm Shares, the “Shares”). The offering and sale of the securities contemplated by this Agreement is referred to herein as the “Offering.”
BIOCARDIA, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • July 23rd, 2019 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
The undersigned, BioCardia, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of ______________ units (the “Firm Units” or “Units”) of the Company’s securities, and, at the election of the Representative, up to an additional ____________ Option Shares (as defined herein and collectively with the shares of Common Stock underlying the Firm Units, the “Shares”), and/or up to an additional ___________ Option Warrants (as defined herein and collectively with warrants underlying the Firm Units, the “Warrants”). Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”) and one Warrant. Each Warrant entitles the holder to purcha
UNDERWRITING AGREEMENT between BIOLINERX LTD. and OPPENHEIMER & CO. INC., as Representative of the Several UnderwritersUnderwriting Agreement • February 7th, 2019 • BioLineRx Ltd. • Pharmaceutical preparations • New York
The undersigned, BioLineRx Ltd., a corporation formed under the laws of the State of Israel (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of BioLineRx Ltd., the “Company”), hereby confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc. (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule I attached hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
ACASTI PHARMA INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 9th, 2018 • Acasti Pharma Inc. • Pharmaceutical preparations • New York
Acasti Pharma Inc., a company incorporated under the laws of the Province of Québec (the "Company"), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule I to this Agreement (the "Underwriters"), for whom you are acting as Representative (the "Representative"), an aggregate of 16,600,000 shares (the "Firm Shares") of the Company's common shares, no par value (the "Common Shares"). The respective amounts of the Firm Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional 2,490,000 shares (the "Option Shares") of Common Shares from the Company for the purpose of covering over-allotments in connection with the sale of the Firm Shares. The Firm Shares and the Option Shares are collectively called the "Shares."
CONSUMER CAPITAL GROUP INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 14th, 2018 • Consumer Capital Group, Inc. • Miscellaneous business credit institution • New York
The undersigned, Consumer Capital Group Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”), subject to the terms and conditions set forth herein, with each of the underwriters listed on Schedule A hereto (collectively, the “Underwriters”), for whom Boustead Securities, LLC is acting as representative (in such capacity, the “Representative”) to issue and sell to the Underwriters an aggregate of [●] shares (“Shares”) of common stock, par value $0.0001 per share, of the Company (“Common Stock”). The offering and sale of securities contemplated by this Agreement is referred to herein as the “Offering.”
Shares of Common Stock and [__________] Warrants to Purchase Shares of Common Stock BLUE SPHERE CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • August 17th, 2017 • Blue Sphere Corp. • Services-computer programming, data processing, etc. • New York
Blue Sphere Corporation, a Nevada corporation (the “Company”), hereby confirms its agreement, subject to the terms and conditions contained in this underwriting agreement (this “Agreement”), to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom Maxim Group LLC (“Maxim”) is acting as Representative (the “Representative,” “you” or similar terminology), an aggregate of [__________] shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), [__________] pre-funded warrants (the “Pre-Funded Warrants”) with the right to purchase one share of Common Stock at an exercise price of $0.01 per share, and [__________] warrants (the “Warrants” and, together with the Shares and the Pre-Funded Warrants, the “Securities”) with the right to purchase one share of Common Stock at an exercise price of $3.30 per share. The respective numbers of Securities to be purchased by each of the several Underwriters ar
Shares of Common Stock and [__________] Warrants to Purchase Shares of Common Stock BLUE SPHERE CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • July 24th, 2017 • Blue Sphere Corp. • Services-computer programming, data processing, etc.
Blue Sphere Corporation, a Nevada corporation (the “Company”), hereby confirms its agreement, subject to the terms and conditions contained in this underwriting agreement (this “Agreement”), to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom Maxim Group LLC (“Maxim”) is acting as Representative (the “Representative,” “you” or similar terminology), an aggregate of [__________] shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), [__________] pre-funded warrants (the “Pre-Funded Warrants”) with the right to purchase one share of Common Stock at an exercise price of $0.01 per share, and [__________] warrants (the “Warrants” and, together with the Shares and the Pre-Funded Warrants, the “Securities”) with the right to purchase one share of Common Stock at an exercise price of $3.30 per share. The respective numbers of Securities to be purchased by each of the several Underwriters ar
IMMUNOCELLULAR THERAPEUTICS, LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • August 3rd, 2016 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • New York
ImmunoCellular Therapeutics, Ltd., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell an aggregate of: (i) [ ] shares (“Firm Shares”) of the Company’s common stock, $0.0001 par value per share (“Shares”), (ii) [ ] warrants to purchase [ ] Shares at an exercise price equal to $[ ] per share (“Base Warrants”), and (iii) [ ] warrants to purchase [ ] Shares at an exercise price equal to $0.01 per share (“Pre-Funded Warrants”) to the several underwriters (such underwriters, for whom Maxim Group LLC (“Maxim” or the “Representative”) is acting as representative, the “Underwriters” and each an “Underwriter”). Each Share shall be sold together with a Base Warrant to purchase 0.75 of a share of common stock; or, alternatively, each Pre-Funded Warrant shall be sold, in lieu of a Share, together with a Base Warrant to purchase 0.75 of a share of common stock. Such [ ] Base Warrants and [ ] Pre-Funded Warrants are hereinafter colle
AXION POWER INTERNATIONAL, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 15th, 2014 • Axion Power International, Inc. • Miscellaneous electrical machinery, equipment & supplies • New York
Axion Power International, Inc., a Delaware corporation (the “Company”), confirms its agreement, subject to the terms and conditions set forth herein, with each of the underwriters listed on Schedule A hereto (collectively, the “Underwriters”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), to sell and issue to the Underwriters an aggregate of _______ shares (the “Firm Shares”) of common stock, par value $.005 per share, of the Company (the “Common Stock”), together with warrants to purchase an aggregate of _______ shares of Common Stock at an exercise price equal to $_______ per share (each a “Firm Warrant” and collectively, the “Firm Warrants”). Each Firm Share shall be accompanied by a Firm Warrant to purchase one additional share of Common Stock.
GALMED PHARMACEUTICALS LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • February 28th, 2014 • Galmed Pharmaceuticals Ltd. • Pharmaceutical preparations • New York
The undersigned, Galmed Pharmaceuticals Ltd., a company incorporated under the laws of Israel (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”, the “Underwriters” and each an “Underwriter”), to sell and issue to the Underwriters an aggregate of [●] ordinary shares, NIS 0.01 par value per share (the “Shares”), of the Company (“Ordinary Shares”). The offering and sale of the securities contemplated by this Agreement is referred to herein as the “Offering.”
4,000,000 SHARES OF COMMON STOCK CHINA FOR-GEN CORP. UNDERWRITING AGREEMENTUnderwriting Agreement • January 7th, 2011 • China for-Gen Corp. • Forestry • New York
UNDERWRITING AGREEMENT between CHINA SHANDONG INDUSTRIES, INC. and RODMAN & RENSHAW, LLC as RepresentativeUnderwriting Agreement • January 3rd, 2011 • China Shandong Industries, Inc. • Wood household furniture, (no upholstered) • New York
The undersigned, China Shandong Industries, Inc., a company formed under the laws of Delaware (collectively with its Subsidiaries (as defined herein) and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being Subsidiaries or affiliates of the Company, the “Company”), hereby confirms its agreement with Rodman & Renshaw, LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
2,100,000 Ordinary Shares (NIS 1.00 par value) STARLIMS Technologies Ltd. UNDERWRITING AGREEMENTUnderwriting Agreement • May 22nd, 2007 • STARLIMS Technologies LTD • Services-prepackaged software • New York
STARLIMS Technologies Ltd., a company incorporated under the laws of the State of Israel (the “Company”), confirms its agreement with Oppenheimer & Co. Inc. (“Oppenheimer”) and each of the underwriters named in Schedule I hereto (collectively, the “Underwriters”), for whom Oppenheimer is acting as the representative (in such capacity, referred to herein as the “Representative”), with respect to the issue and sale by the Company, and the purchase by the Underwriters, acting severally and not jointly, of 2,100,000 ordinary shares, NIS 1.00 par value per share (“Ordinary Shares”). Such Ordinary Shares are hereinafter referred to as the “Firm Shares.”
